Update to U.S. Selected Practice Recommendations for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate
Kathryn M. Curtis(National Center for Chronic Disease Prevention and Health Promotion), Maura K. Whiteman(National Center for Chronic Disease Prevention and Health Promotion), Suzanne G. Folger(National Center for Chronic Disease Prevention and Health Promotion), Elizabeth Clark(National Center for Chronic Disease Prevention and Health Promotion), Jennifer A. Reeves(National Center for Chronic Disease Prevention and Health Promotion), Antoinette T. Nguyen(University of Alberta)
Cited by 35
Related Papers
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
|MMWR Recommendations and Reports|2016|1.5k
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|195
Abortion Surveillance — United States, 2019
|MMWR Surveillance Summaries|2021|141
Using a Patient Navigator to Improve Postpartum Care in an Urban Women's Health Clinic
|Obstetrics and Gynecology|2017|137
U.S. Selected Practice Recommendations for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|120